Accelerate Diagnostics, Inc. (AXDX) News
Filter AXDX News Items
AXDX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest AXDX News From Around the Web
Below are the latest news stories about ACCELERATE DIAGNOSTICS INC that investors may wish to consider to help them evaluate AXDX as an investment opportunity.
Accelerate Diagnostics (AXDX) Expands in In Vitro DiagnosticsAccelerate Diagnostics' (AXDX) Arc system eliminates the need for overnight culture incubation, drastically reducing the wait time for identification results. |
Bruker's (BRKR) New Collaboration to Use MALDI Biotyper SystemBruker (BRKR) and Accelerate Diagnostics are set to work together to bring rapid, automated microbial identification directly from positive blood culture samples. |
Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the signing of a collaboration and quality agreement with Bruker Corporation (NASDAQ: BRKR), the provider of the market-leading MALDI Biotyper system for microbial identification. This agreement enables both companies to validate the use of Accelerate Diagnostics' Arc™ system, an innovative, automated positive blood culture sample preparation platform, with Bruker's MALDI Biotyper® s |
Accelerate Diagnostics (AXDX) Loses -25.65% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerAccelerate Diagnostics (AXDX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock. |
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q3 2023 Earnings Call TranscriptAccelerate Diagnostics, Inc. (NASDAQ:AXDX) Q3 2023 Earnings Call Transcript November 9, 2023 Accelerate Diagnostics, Inc. beats earnings expectations. Reported EPS is $0.14, expectations were $-0.94. Operator: Good day, and welcome to the Accelerate Diagnostics, Inc. 2023 Third Quarter Results Conference Call. All participant’s will be in listen-only mode. After today’s presentation, there will be a […] |
Accelerate Diagnostics Reports Third Quarter 2023 ResultsAccelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter ended September 30, 2023. |
Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, November 9, 2023, at 4:30 p.m. Eastern Time to review 2023 third quarter results. |
Accelerate Diagnostics (AXDX) Moves 12.7% Higher: Will This Strength Last?Accelerate Diagnostics (AXDX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. |
Insider Sell: CEO Jack Phillips Sells 733 Shares of Accelerate Diagnostics IncOn September 13, 2023, Jack Phillips, the CEO of Accelerate Diagnostics Inc (NASDAQ:AXDX), sold 733 shares of the company. |
Q2 2023 Accelerate Diagnostics Inc Earnings CallQ2 2023 Accelerate Diagnostics Inc Earnings Call |